Showing 1,441 - 1,460 results of 1,680 for search '"myocardial"', query time: 0.06s Refine Results
  1. 1441

    Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease by Caterina Oriana Aragona, Egidio Imbalzano, Federica Mamone, Valentina Cairo, Alberto Lo Gullo, Angela D’Ascola, Maria Adriana Sardo, Michele Scuruchi, Giorgio Basile, Antonino Saitta, Giuseppe Mandraffino

    Published 2016-01-01
    “…MEDLINE was searched using keywords related to “endothelial progenitor cells” and “endothelium” and, for the different categories, respectively, “smoking”; “blood pressure”; “diabetes mellitus” or “insulin resistance”; “dyslipidemia”; “aging” or “elderly”; “angina pectoris” or “myocardial infarction”; “stroke” or “cerebrovascular disease”; “homocysteine”; “C-reactive protein”; “vitamin D”. …”
    Get full text
    Article
  2. 1442

    Syndecan-1: A Review on Its Role in Heart Failure and Chronic Liver Disease Patients’ Assessment by Radu-Stefan Miftode, Ionela-Lăcrămioara Şerban, Amalia-Stefana Timpau, Ionela-Larisa Miftode, Adriana Ion, Ana-Maria Buburuz, Alexandru-Dan Costache, Irina-Iuliana Costache

    Published 2019-01-01
    “…Multiple evidence revealed that syndecan-1 is also associated with tissue injury and may regulate inflammatory and regenerative responses, being considered a protective molecule that limits the inflammation and reduces cardiac remodelling and dysfunction after a myocardial infarction. Syndecan-1 may also be used as a reliable biomarker for the noninvasive assessment of liver fibrosis. …”
    Get full text
    Article
  3. 1443

    The effect of thermoelectric craniocerebral cooling device on protecting brain functions in post-cardiac arrest syndrome by Aydın Nadir, Deniz Kara, Ayda Turkoz

    Published 2025-01-01
    “…Among the patients, 62.5% underwent emergency coronary angiography due to ST-elevation myocardial infarction (STEMI). The mean time to hypothermia initiation was 32.9 ± 13.5 min, with hypothermia maintained for 58 ± 6.4 h. …”
    Get full text
    Article
  4. 1444

    Advances in genetic diagnosis and therapy of hereditary heart disease: a bibliometric review from 2004 to 2024 by Huixi Ma, Yun Wang, Yang Jia, Linjun Xie, Lini Liu, Dingyi Zhang, Xinyue Ma, Yingkun Guo, Rong Xu

    Published 2025-01-01
    “…Hypertrophic cardiomyopathy (HCM), arrhythmogenic cardiomyopathy (ACM), Brugada syndrome (BrS), myocardial amyloidosis, and Fabry disease (FD) were the main types of HHD that were explored in greater depth. …”
    Get full text
    Article
  5. 1445
  6. 1446

    Stentless Strategy by Drug-Coated Balloon Angioplasty following Directional Coronary Atherectomy for Left Main Bifurcation Lesion by Norihiro Kobayashi, Masahiro Yamawaki, Shinsuke Mori, Masakazu Tsutsumi, Yohsuke Honda, Kenji Makino, Shigemitsu Shirai, Masafumi Mizusawa, Yoshiaki Ito

    Published 2021-01-01
    “…There was no cardiac death, no myocardial infarction, no coronary artery bypass grafting, and no bleeding complications at 12 months. …”
    Get full text
    Article
  7. 1447

    N-Cadherin promotes cardiac regeneration by potentiating pro-mitotic β-Catenin signaling in cardiomyocytes by Yi-Wei Tsai, Yi-Shuan Tseng, Yu-Shuo Wu, Wei-Lun Song, Min-Yi You, Yun-Chia Hsu, Wen-Pin Chen, Wei-Han Huang, Jia-Ci Chng, Chai-Ling Lim, Ke-Hsuan Wei, Shih-Lei Ben Lai, Wen-Chih Lee, Kai-Chien Yang

    Published 2025-01-01
    “…Post-injury cardiomyocyte (CM) loss can lead to myocardial dysfunction and failure. Although neonatal mammalian hearts can regenerate, the underlying molecular mechanisms remain elusive. …”
    Get full text
    Article
  8. 1448

    ClimaWATCH: A new interactive tool for community heat-health vulnerability assessments by Aparna Keshaviah, Dheeya Rizmie, Huihua Lu, Mike Rudacille, Eric Morris, Colleen Psomas, Farid Qamar, Xindi C. Hu

    Published 2025-01-01
    “…Nationally in 2020, excess Medicaid spending amounted to $18 million on heat stress, $15 million on electrolyte imbalance, $25 million on acute myocardial infarction, and $133 million on acute renal failure. …”
    Get full text
    Article
  9. 1449

    Pooled Multicenter Safety Analysis of Lupin’s Intravitreal Biosimilar Ranibizumab (Ranieyes) in Chorioretinal Vascular Diseases by Debdulal Chakraborty, Tushar Kanti Sinha, Sourav Sinha, Aniruddha Maiti, Angshuman Mukherjee, Krishnendu Nandi, Sudipta Das, Saptorshi Majumdar, Dinesh Rungta, Ranabir Bhattacharya

    Published 2024-11-01
    “…One patient developed non-fatal myocardial infarction, the causal relationship of which, however, was not established with the intravitreal agent used. …”
    Get full text
    Article
  10. 1450

    Evidence for a Specific Diabetic Cardiomyopathy: An Observational Retrospective Echocardiographic Study in 656 Asymptomatic Type 2 Diabetic Patients by Isabelle Pham, Emmanuel Cosson, Minh Tuan Nguyen, Isabela Banu, Isabelle Genevois, Patricia Poignard, Paul Valensi

    Published 2015-01-01
    “…Methods. 656 asymptomatic patients with type 2 diabetes for 14 ± 8 years (359 men, 59.7 ± 8.7 years old, HbA1c 8.7 ± 2.1%) and at least one cardiovascular risk factor had a cardiac echography at rest, a stress cardiac scintigraphy to screen for silent myocardial ischemia (SMI), and, in case of SMI, a coronary angiography to screen for silent CAD. …”
    Get full text
    Article
  11. 1451

    Correlation between mitral annular plane systolic excursion (MAPSE) at different degrees of ejection fraction in patients with diabetes mellitus by Muhammad Rido, Khalid Saleh, A. Makbul Aman, Syakib Bakri, Haerani Rasyid, Andi Alfian Zainuddin

    Published 2024-09-01
    “…Diabetic cardiomyopathy is characterized by myocardial structure and function abnormality in the absence of other cardiovascular risk factors. …”
    Get full text
    Article
  12. 1452

    Prognostic Value of Atherosclerotic Extent in Diabetic Patients with Nonobstructive Coronary Artery Disease by Yipu Ding, Zinuan Liu, Guanhua Dou, Xia Yang, Xi Wang, Dongkai Shan, Bai He, Jing Jing, Yundai Chen, Junjie Yang

    Published 2021-01-01
    “…During a median follow-up of 31.77 months, 50 major adverse cardiovascular events (MACEs) (6.15%) were experienced, including 2 cardiovascular deaths, 14 nonfatal myocardial infarctions, 27 unstable anginas requiring hospitalization, and 7 strokes. …”
    Get full text
    Article
  13. 1453

    Malignant Paraganglioma With Calvarial Metastases Presenting With Recurrent Catecholamine-Induced Cardiomyopathy by Beatrice A. Brumley, MD, Run Yu, MD, PhD, Shadfar Bahri, MD, Jane Rhyu, MD

    Published 2025-01-01
    “…After being lost to follow-up, the patient presented emergently with headache, palpitations, hypertensive crisis, type 2 non-ST-elevation myocardial infarction, and catecholamine-induced cardiomyopathy, with plasma free metanephrine level of 61.0 pg/mL (0.0-88.0 pg/mL) and elevated serum free normetanephrine level of 662.9 pg/mL (0.0-210.1 pg/mL). …”
    Get full text
    Article
  14. 1454

    Impact of multimorbidity on long-term outcomes in older adults with non-ST elevation acute coronary syndrome in the North East of England: a multi-centre cohort study of patients u... by Chris Wilkinson, Vijay Kunadian, Benjamin Beska, Abdulla A Damluji, Hanna Ratcovich, Greg B Mills

    Published 2022-07-01
    “…The primary composite outcome was all-cause mortality, myocardial infarction, stroke, urgent repeat revascularisation or significant bleeding.Results Mean age was 80.9 (±6.1) years. …”
    Get full text
    Article
  15. 1455

    Long term cost-effectiveness analysis of IDegLira in the treatment of type 2 diabetes patients compared to GLP-1RA added to basal insulin after IDegLira entered the national reimbu... by Dunming Xiao, Junling Weng, Lei Zhang, Chang Xing, Yan Wei, Yingyao Chen

    Published 2025-01-01
    “…Ischemic heart disease, heart failure, and myocardial infarction (stroke) decreased by 0.8%, 1.1%, and 4.7%, respectively. …”
    Get full text
    Article
  16. 1456
  17. 1457

    A real-world Pharmacovigilance study of brodalumab based on the FDA adverse event reporting system by Ke He, Kaidi Zhao, Tingyi Yin, Meng Liu, Jiashu Liu, Wenqian Du, Xinyi Liu, Baochen Cheng, Dewu Zhang, Yan Zheng

    Published 2025-01-01
    “…Additionally, we found potential adverse reactions not noted on the drug’s label that exhibited positive signals, including depression, increased blood pressure, peripheral swelling, gait disturbance, inability to walk, stress, myocardial infarction, sepsis, uveitis, nephrolithiasis, and interstitial lung disease. …”
    Get full text
    Article
  18. 1458

    TRIM26 exacerbates pathological cardiac hypertrophy by activating TAK1 by Xiaochuang Xia, Huajing Shan, Zhaoxia Jin, Tengfei Ma, Yemao Liu, Jianqing Zhang, Han Tian, Bizhen Dong, Chengsheng Xu, Shaoze Chen

    Published 2025-01-01
    “…Pathological myocardial hypertrophy can induce heart failure with high mortality, it is necessary to explore its pathogenesis. …”
    Get full text
    Article
  19. 1459

    The predictive value of optic nerve sheath diameter measurement via ultrasound for intracerebral hemorrhage complicated by cerebral-cardiac syndrome by Wei-Ze Fan, Jun-Rong Jiang, Hui-Ling Zang, Hui Cheng, Xiao-Hui Shen, Wen-Juan Yang, Hui Wang, Li-Xing Jing

    Published 2025-01-01
    “…Various clinical parameters, including sex, age, electrocardiogram (ECG) findings, myocardial markers, B-type natriuretic peptide (BNP) levels, Glasgow Coma Scale (GCS) score, ONSD, hematoma volume, and midline shift, were assessed. …”
    Get full text
    Article
  20. 1460

    Preparation of recombinant myoglobin and investigation of the liquid antigen stability for quality control materials by Yu-Hui Wang, Xi-Feng Sun, Chun-Xin Xu, Feng-Qiang Sun, Rong-Rong Wang, Xiao-Kun Bian, Zhan-Zhao Wang, Qiang Wu

    Published 2025-04-01
    “…Myoglobin (Mb) has been used as a biomarker for acute myocardial infarction. This study aimed to evaluate the stability of liquid Mb as quality control materials for Mb determination. …”
    Get full text
    Article